Medication info
Diagryl-MEX Controlled Release Tablet 2/500 Milligrams

Diagryl-MEX Controlled Release Tablet 2/500 Milligrams

Prescription medicationTabletOral
Ingredient · strength
Glimepiride›2mg / 1 tabletMetformin Hydrochloride›500mg / 1 tablet
Manufacturer / importer
Bukwang Pharmaceutical Co., Ltd.
Appearance
White, rectangular, film-coated, triple-layered tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 201206792 · Approved 2012.09.14

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The dose of antidiabetic agents should be adjusted according to each patient's blood glucose level. Refer to the following to initiate this medicine at the lowest possible dose. 1) When blood glucose is not adequately controlled with sulfonylurea or metformin monotherapy: The usual initial dose is 2/500mg of glimepiride/metformin hydrochloride per day. The dose may be adjusted according to the patient's current medications and blood glucose level. If a long-acting sulfonylurea (e.g., chlorpropamide) was used before starting this medicine, monitor carefully to prevent hypoglycemia due to excessive pharmacological effects. 2) When used as a substitute for combination therapy: Administer the same total daily doses of glimepiride and metformin hydrochloride as those previously taken. If necessary, increase the dose based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended doses of each component: glimepiride 8mg and metformin 2000mg. Appropriate blood glucose monitoring should be performed for this purpose. Glimepiride generally provides little additional benefit at doses above 4mg, although some patients have achieved better metabolic control when the dose was increased to 6mg (or 8mg). Administer this medicine once daily immediately before or with breakfast or the main meal. Do not take more than one dose at the next scheduled administration, even if a dose was missed. This medicine is an extended-release formulation; swallow it whole without breaking or chewing it. (See General Precautions)

Ingredients

Manufacturer
Bukwang Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

View approved original text

This medication is used to effectively enhance blood sugar control for patients with type 2 diabetes who are following dietary and exercise regimens.

How to take

Adult dose

The dose of antidiabetic agents should be adjusted according to each patient's blood glucose level. Refer to the following to initiate this medicine at the lowest possible dose. 1) When blood glucose is not adequately controlled with sulfonylurea or metformin monotherapy: The usual initial dose is 2/500mg of glimepiride/metformin hydrochloride per day. The dose may be adjusted according to the patient's current medications and blood glucose level. If a long-acting sulfonylurea (e.g., chlorpropamide) was used before starting this medicine, monitor carefully to prevent hypoglycemia due to excessive pharmacological effects. 2) When used as a substitute for combination therapy: Administer the same total daily doses of glimepiride and metformin hydrochloride as those previously taken. If necessary, increase the dose based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended doses of each component: glimepiride 8mg and metformin 2000mg. Appropriate blood glucose monitoring should be performed for this purpose. Glimepiride generally provides little additional benefit at doses above 4mg, although some patients have achieved better metabolic control when the dose was increased to 6mg (or 8mg). Administer this medicine once daily immediately before or with breakfast or the main meal. Do not take more than one dose at the next scheduled administration, even if a dose was missed. This medicine is an extended-release formulation; swallow it whole without breaking or chewing it. (See General Precautions)

Precautions

This medication can cause severe lactic acidosis or hypoglycemia, which requires caution. Particularly, if renal function rapidly declines, the risk of lactic acidosis may increase due to drug accumulation. If dehydration symptoms occur, the medication should be temporarily discontinued, and consultation with a physician is advised. Additionally, the risk of cardiovascular disease may increase, so careful observation is necessary before and after treatment. It should not be administered to patients with type 1 diabetes, acute metabolic acidosis, or severe liver or kidney dysfunction. Patients undergoing surgery or those with severe infections or serious trauma may also need to temporarily discontinue use. Elderly patients or those with poor nutritional status and irregular eating habits should also exercise caution due to the risk of hypoglycemia. Gastrointestinal disturbances (such as diarrhea and vomiting) may occur during the initial use of this medication, but these typically improve over time. If allergic reactions, severe skin rashes, or blood abnormalities occur, notify a physician immediately. Do not crush or chew this medication; swallow it whole, and regular monitoring of blood sugar and kidney function is required during treatment. Alcohol consumption may affect the drug's efficacy, so it is better to avoid it. It is safest not to use this medication during pregnancy or breastfeeding. When used in combination with other drugs, the possibility of interactions exists, so always consult healthcare professionals. In cases of overdose, serious side effects such as hypoglycemia or lactic acidosis can occur, necessitating immediate emergency treatment. Especially in the elderly, where renal function decline is common, dose adjustment and regular monitoring are important. This medication should be stored out of the reach of children for safety.

Side effects

  • lactic acidosis
  • hypoglycemia
  • diarrhea
  • nausea
  • vomiting
  • abdominal swelling
  • flatulence
  • loss of appetite
  • metallic taste
  • vision impairment
Show 32 more
  • taste disorder
  • itching
  • hives
  • rash
  • thrombocytopenia
  • leukopenia
  • hemolytic anemia
  • decreased vitamin B12
  • peripheral neuropathy
  • megaloblastic anemia
  • increased liver enzymes
  • liver dysfunction
  • bile secretion disorder
  • jaundice
  • hepatitis
  • allergic vasculitis
  • photosensitivity
  • decreased serum sodium concentration
  • hypothyroidism
  • magnesium deficiency due to diarrhea
  • encephalopathy
  • hair loss
  • weight gain
  • upper abdominal pain
  • abdominal discomfort
  • abnormal bowel sounds
  • constipation
  • indigestion
  • hyperkalemia
  • hypertension
  • flushing
  • cold

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. The recommended storage temperature is between 1 to 30 degrees Celsius at room temperature. Proper storage will help maintain the drug's efficacy.

Appearance and packaging

Appearance

White, rectangular, film-coated, triple-layered tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.